Characterization of pancreastatin receptors and signaling in adipocyte membranes

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1451, Issue 1, 1999, Pages 153-162

  González Yanes, Carmen ^a   Santos Alvarez, José ^a   Sánchez Margalet, Víctor ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Adipose tissue; G protein; Insulin resistance; Pancreastatin receptor; Phospholipase C; Signaling

Indexed keywords

ADENYLATE CYCLASE; PANCREASTATIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BINDING SITE; CELL MEMBRANE; CONTROLLED STUDY; MEMBRANE BINDING; MEMBRANE STRUCTURE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ADENYLATE CYCLASE TOXIN; ADIPOCYTES; ANIMALS; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); INOSITOL PHOSPHATES; MALE; MEMBRANES; PANCREATIC HORMONES; PERTUSSIS TOXIN; PHOSPHOLIPASE C; RATS; RATS, WISTAR; RECEPTORS, GASTROINTESTINAL HORMONE; SIGNAL TRANSDUCTION; VIRULENCE FACTORS, BORDETELLA;

EID: 19244369409     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(99)00084-1     Document Type: Article

References (50)

1. Tatemoto K., Efendic S., Mutt V., Makk G., Feistner G.J., Barchas J.C. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature. 324:1986;476-478.
2. Iancangelo A.L., Affolter H.U., Eiden L.E., Herbert E., Grimes M. Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues. Nature. 323:1986;82-86.
3. Iancangelo A.L., Fischer-Colbrie R., Koller K.J., Brownstein M.J., Eiden L.E. The sequence of porcine chromogranin A messenger RNA demonstrates chromogranin A can serve as the precursor for the biologically active hormone, pancreastatin. Endocrinology. 15:1988;2339-2341.
4. Eskeland N.L., Zhou A., Dihn T.Q., Wu H., Parmer R.J., Mains E., O'Connor D.T. Chromogranin A processing and secretion. Specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway. J. Clin. Invest. 98:1996;148-156.
5. Parmer R.J., Xi X.-P., Wu H.-J., Helman L.J., Petz L.N. Secretory protein traffic. Chromogranin A contains a dominant targeting signal for the regulated pathway. J. Clin. Invest. 92:1993;1042-1054.
6. Sánchez-Margalet V., Lucas M., Goberna R. Pancreastatin: further evidence for its consideration as a regulatory peptide. J. Mol. Endocrinol. 16:1996;1-8.
7. Sánchez-Margalet V., Lucas M., Goberna R. Pancreastatin action in the liver: dual coupling to different G proteins. Cell. Signal. 8:1996;9-12.
8. Sánchez-Margalet V., Goberna R. Pancreastatin inhibits insulin-stimulated glycogen synthesis but not glycolysis in rat hepatocytes. Regul. Pept. 51:1994;215-220.
9. Sánchez V., Calvo J.R., Goberna R. Glycogenolytic effect of pancreastatin in the rat. Biosci. Rep. 10:1990;87-91.
10. Sánchez-Margalet V., Calvo J.R., Goberna R. Glycogenolytic and hyperglycemic effect of 33-49 C-terminal fragment of pancreastatin in the rat in vivo. Horm. Metab. Res. 34:1992;455-457.
11. 2+-dependent mechanism. Biochem. J. 284:1992;659-662.
12. Sánchez-Margalet V., Lucas M., Goberna R. Pancreastatin increases free cytosolic Ca2+ in rat hepatocytes involving both pertussis-toxin-sensitive and insensitive mechanisms. Biochem. J. 294:1993;439-442.
13. Sánchez-Margalet V., Goberna R. Pancreastatin activates pertussis toxin-sensitive guanylate cyclase and pertussis toxin-insensitive phospholipase C in rat liver membranes. J. Cell. Biochem. 55:1994;173-181.
14. Sánchez-Margalet V., Lucas M., Goberna R. Pancreastatin activates protein kinase C by stimulating the formation of 1,2-diacylglycerol in rat hepatocytes. Biochem. J. 303:1994;51-54.
15. Sánchez-Margalet V., Valle M., Goberna R. Receptors for pancreastatin in rat liver membranes: molecular identification and characterization by covalent cross-linking. Mol. Pharmacol. 46:1994;24-29.
16. Sánchez-Margalet V., Santos-Alvarez J. Solubilization and molecular characterization of pancreastatin receptors from rat liver membranes. Endocrinology. 138:1997;1712-1718.
17. q/11α in rat liver membranes. Hepatology. 27:1998;608-614.
18. 11 protein stimulation in rat liver membranes. Mol. Cell. Endocrinol. 143:1998;101-106.
19. Sánchez-Margalet V., González-Yanes C. Pancreastatin inhibits insulin action in rat adipocytes. Am. J. Physiol. 275:1998;E1055-E1060.
20. Hunter W.M., Greenwood F.C. The preparation of 125I-labeled human growth hormone of high specific radioactivity. Nature. 19:1962;495-496.
21. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
22. Smith C.D., Uhing R.J., Snyderman R. Nucleotide regulatory protein-mediated activation of phospholipase C in human polymorphonuclear leukocytes is disrupted by phorbol esters. J. Biol. Chem. 262:1987;6121-6127.
23. i1,2 protein in rat hepatoma (HTC) plasma membranes. Cell. Mol. Life Sci. 55:1999;142-147.
24. 32P, J. Cell. Biochem. (1999) in press.
25. Al-Aoukaty A., Schall T.J., Maghazachi A.A. Differential coupling of CC chemokine receptors to multiple heterotrimeric G proteins in human interleukin-2-activated natural killer cells. Blood. 87:1996;4255-4260.
26. Jouneaux C., Mallat A., Serradail-Le Gal C., Goldsmith P., Hanoune J., Lotersztajn S. Coupling of endothelin B receptors to the calcium pump and phospholipase C via Gs and Gq in rat liver. J. Biol. Chem. 269:1994;1845-1851.
27. Shenker A., Goldsmith P., Unson C.G., Spiegel A.M. The G protein coupled to the thromboxane A2 receptor in human platelets is a member of the novel Gq family. J. Biol. Chem. 266:1991;9309-9313.
28. Schelling J.R., Nkemere N., Konieczkowski M., Martin K.A., Dubyak G.R. Angiotensin II activates the β1 isoform of phospholipase C in vascular smooth muscle cells. Am. J. Physiol. 272:1997;C1558-C1566.
29. Sánchez-Margalet V., Goldfine I.D., Truitt K., Imboden J., Sung C.K. Role of p85 subunit of phosphatidylinositol-3-kinase as an adaptor molecule linking the insulin receptor to insulin receptor substrate 1. Mol. Endocrinol. 9:1995;435-442.
30. Gutowski S., Smrcka A., Nowak L., Wu D., Simon M., Sternweis P.C. Antibodies to the αq subfamily of guanine nucleotide-binding regulatory protein α subunits attenuate activation of phosphatidylinositol 4,5-bisphosphate hydrolysis by hormones. J. Biol. Chem. 266:1991;20519-20524.
31. V. Sánchez-Margalet, R. Goberna, Pancreastatin, a new peptide associated with essential hypertension and hyperinsulinemia, in: M.M. Galteau, J. Henny, G. Siest (Eds.), Biologic Prospective, Libbey, Paris, 1993, pp. 575-580.
32. V. Sánchez-Margalet, J. Santos-Alvarez, R. Goberna, Pancreastatin signaling in the liver, in: Neurochemistry: Cellular, Molecular and Clinical Aspects, Plenum, New York, 1997, pp. 589-593.
33. Sánchez-Margalet V. Modulation of insulin receptor signalling by pancreastatin in HTC hepatoma cells. Diabetologia. 42:1999;317-325.
34. Funakoshi A., Tateishi K., Shinozaki H., Matsumoto M., Wakasugi H. Elevated plasma levels of pancreastatin (PST) in patients with non-insulin-dependent diabetes mellitus (NIDDM). Regul. Pept. 30:1990;159-164.
35. Sánchez-Margalet V., Lobón J.A., Gonzalez A., Escobar-Jimenez F., Goberna R. Increased plasma pancreastatin-like levels in gestational diabetes subjects. Correlation with plasma catecholamine levels. Diabetes Care. 21:1998;1951-1954.
36. Sánchez-Margalet V., Valle M., Lobón J.A., Maldonado A., Escobar F., Oliván J., Perez-Cano R., Goberna R. Increased plasma pancreastatin-like immunoreactivity levels in non-obese patients with essential hypertension. J. Hypertens. 13:1995;251-258.
37. Sánchez-Margalet V., Valle M., Lobón J.A., Escobar-Jimenez F., Perez-Cano R., Goberna R. Plasma pancreastatin-like immunoreactivity correlates with plasma norepinephrine levels in essential hypertension. Neuropeptides. 29:1995;97-101.
38. Begum N., Sussman K.E., Draznin B. Calcium-induced inhibition of phosphoserine phosphatase in insulin target cells is inhibited by the phosphorylation and activation of inhibitor 1. J. Biol. Chem. 267:1992;5959-5963.
39. Exton J.H. Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins. Annu. Rev. Pharmacol. Toxicol. 36:1996;481-509.
40. 11α. Activation of phospholipase C isoenzymes by Gα subunits. J. Biol. Chem. 268:1993;14367-14375.
41. qα subunit gene family activate phospholipase C β isozymes. J. Biol. Chem. 267:1992;16044-16047.
42. Schelling J.R., Nkemere N., Konieczkowski M., Martin K.A., Dubyak G.R. Angiotensin II activates the β1 isoform of phospholipase C in vascular smooth muscle cells. Am. J. Physiol. 272:1997;C1558-C1566.
43. Jiang H., Wu D., Simon M.I. Activation of phospholipase C β4 by heterotrimeric GTP-binding proteins. J. Biol. Chem. 269:1994;7593-7596.
44. Ni Z., Smogorzewski M., Massry S.G. Effects of parathyroid hormone on cytosolic calcium of rat adipocytes. Endocrinology. 135:1994;1837-1844.
45. Berridge M.J. Inositol triphosphate and diacylglycerol: two interacting second messengers. Annu. Rev. Biochem. 56:1987;159-193.
46. Reusch J.E.-B., Begum N., Sussman K.E., Draznin B. Regulation of GLUT-4 phosphorylation by intracellular calcium in adipocytes. Endocrinology. 129:1991;3269-3273.
47. Arrese E.L., Flowers M.T., Gazard J.L., Wells M.A. Calcium and cAMP are second messengers in the adipokinetic hormone-induced lipolysis of triacylglycerols in manduca sexta fat body. J. Lipid Res. 40:1999;556-564.
48. Goren H.J., Hanif K., Dudley R., Hollenberg M.D., Lederis K. Adenosine modulation of fat cell responsiveness to insulin and oxytocin. Regul. Pept. 16:1986;125-134.
49. Lee H.M., Fain J.N. Regulation of oxytocin-induced phosphoinositide breakdown in adipocytes by adenosine, isoproterenol and insulin. Biochim. Biophys. Acta. 1013:1989;73-79.
50. Kelly K.L., Deeney J.T., Corkey B.E. Cytosolic free calcium in adipocytes. Distinct mechanisms of regulation and effects on insulin action. J. Biol. Chem. 264:1989;12754-12757.